Cormorant Asset Management’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q3
Sell
-1,754,795
Closed -$18.9M 92
2016
Q2
$18.9M Buy
1,754,795
+19,795
+1% +$214K 2.69% 11
2016
Q1
$11.5M Buy
1,735,000
+1,111,591
+178% +$7.37M 1.73% 22
2015
Q4
$11.3M Buy
+623,409
New +$11.3M 1.35% 29